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INTRODUCTION 
Dementia is characterized by a 
progressive decline in cognitive function 
depending on neurodegeneration, which 
particularly affects elder population in their 
daily activities such as memory, speaking, 
and problem dissolving. The most  
well-known type of dementia is Alzheimer’s 
disease (AD), which proceeds at stages from 
mild and moderate to severe and gradually 
destroys the brain. Brain aging is known to 
be related to excessive neuronal loss, 
decrease in Acetylcholine level, increase in 
inflammation, and oxidative stress.
1
 There 
have been some hypotheses to explain 
pathogenesis of the disease such as cholinergic 
hypothesis and amyloid formation hypothesis. 
Nowadays, the most accepted treatment 
strategy in AD has been accepted as 
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ABSTRACT 
Background and aims: The spice Zingiber officinale or ginger possesses antioxidant activity 
and neuroprotective effects. In this study we hypothesized that treatment with hydroethanolic 
extract of ginger (50, 100 and 200 mg/kg, p.o) would effect on the scopolamine-induced 
memory impairment in rats. 
Methods: In this experimental study, 64 male Wistar rats were divided into eight groups  
(8 rats in each group): normal saline, scopolamine (1 mg/kg), ginger extract (50, 100 and 200 
mg/kg), or scopolamine (1 mg/kg) plus ginger extract (50, 100 and 200 mg/kg). Memory 
impairment was induced by a single injection of scopolamine (1 mg/kg, i.p). Cognitive 
functions were evaluated using passive avoidance learning (PAL) task. Retention test was 
carried out 24 h after training, and the latency of entering the dark compartment [step-through 
latency (STL)] and the total time in the dark compartment (TDC) were recorded. All statistical 
analysis was carried out at 5% level of significance using SPSS version 21. The data were 
analyzed by ANOVA followed by Tukey’s test. 
Results: The time latency in scopolamine-treated group was lower than control (P<0.001). 
Treatment of the animals by 100 and 200 mg/kg of ginger extract before the training trial 
increased the time latency at 24 h after the training trial (P<0.01). Administration of both 100 
and 200 mg/kg doses of the extract in scopolamine received animal groups before retention 
trials also increased the time latency than the scopolamine-treated groups (P<0.001). 
Conclusion: The results revealed that the ginger hydroethanolic extract attenuated 
scopolamine-induced memory impairment. 
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cholinesterase inhibitors that can inhibit 
Acetylcholinesterase (AChE) enzyme in order 
to increase Acetylcholine level in the brain.
2
 
Acetylcholine (ACh) is known to regulate 
the learning and memory process.
3
 It was 
reported that ACh activity was increased in 
the training of spatial memory performance 
and it was decreased in memory deficit.
4
 
Scopolamine (Hyoscine-N-Butyl bromide), an 
anti-cholinergic agent, is used as a standard 
drug for inducing cognitive deficits in healthy 
humans and animals.
5
 It is a muscarinic 
receptor antagonist with amnestic properties 
and is a widely used model for characterizing 
potential cognition enhancing drugs.
6
 
Blockade of central muscarinic receptors may 
induce a pattern of cognitive impairment in 
Alzheimer disease (AD) patients.
7
 Therefore, 
scopolamine challenge is very useful for 
investigating learning and memory studies in 
which the cholinergic system is involved.
8
 
Zingiber officinale Roscoe (Zingiberaceae), 
or ginger, is one of the frequently used 
spices in the world. Ginger has been 
cultivated for thousands of years and used 
safely in cooking, and medicinally in folk 
and home remedies. It is used extensively in 
traditional medicine to treat cold, fever, 
headache, nausea and digestive problems. It 
is also used in Western herbal medical 
practices for the treatment of arthritis, 
rheumatic disorders and muscular 
discomfort.
9
 It has been reported that ginger 
or its extracts possess some pharmacological 
activities including analgesic, antioxidant, 
anti-inflammatory, anticonvulsant and 
neuroprotective effects.
10
 In folklore 
medicine, including Ayurveda and 
traditional Chinese medicine ginger has 
been reported used for the 
management/treatment of Alzheimer’s 
disease either as ginger extract, ginger tea or 
as inclusion in food formulations and 
preparation.
11
 Numerous experimental 
studies and clinical observations indicate 
that ginger influences some central nervous 
systems,
12
 but accurate mechanisms of its 
action are not precisely known. Although 
ginger has been an important ingredient in 
folk medicine for the treatment of 
Alzheimer’s disease, nevertheless, limited 
information is available on the possible 
mechanism that ginger renders its  
anti-Alzheimer properties. Therefore, with 
regard to the possible effects of ginger on 
learning and memory and its interactions 
with cholinergic system, the aim of the 
present study was to evaluate the effect of 
hydroethanolic extract of Z. officinale on 
scopolamine-induced memory impairment 
in rats using the passive avoidance test. 
 
 
METHODS 
The fresh rhizomes of ginger 
(herbarium code no. 1483) were purchased 
from the Institute of Medicinal Plants in 
Tehran, Iran. The plant material was dried 
with room temperature (25°C), shade dried 
and powdered. Approximately, 500 g of the 
dried powder from ginger were extracted 
with 5 liters of 80% aqueous ethanol using 
the percolation method at room temperature. 
The extracts were filtered through filter 
paper and evaporated to dryness under 
reduced pressure at a maximum of 40°C 
using a rotary evaporator. Z. officinale 
yielded 43.25% dried extract. The 
hydroethanolic extract of ginger was stored 
in small samples at -20°C. The extract was 
dissolved in saline and was then applied. 
The drugs used in the present study were 
scopolamine (hyoscine-N-butyl bromide) 
(Osvah, Tehran, Iran). Scopolamine dissolved 
in physiologic saline solution. 
In this experimental study, 64 locally 
produced male Wistar rats (250–280 g) from 
the Iranian Razi Institute, were used in the 
present experiments. All animals were 
maintained at a constant temperature 
(22±2°C) and on a 12 h light/dark cycle. 
They had free access to laboratory chow and 
tap water. The animals were maintained 
Advanced Herbal Medicine, 2015; 1(4): 35-42. 
37 
under laboratory conditions for an 
acclimatization period of 7 days before 
performing the experiment. Each 
experimental group consisted of eight 
animals that were chosen randomly from 
different cages. Each rat was used only 
once. Animals were handled in accordance 
with the criteria outlined in the Guide for the 
Care and Use of Laboratory Animals 
(National Institutes of Health (NIH) 
publication 86–23; revised 1985). 
The animals were divided into eight equal 
groups (n= 8); (1): Control group received 
normal saline (p.o by gavage), (2): Control 
group received scopolamine at dose 1 mg/kg 
via i.p injection 30 min before training, (3-5): 
groups received ginger extract at doses 50, 
100 and 200 mg/kg (p.o by gavage) 30 min 
before training, (6-8): groups received 
scopolamine at dose 1 mg/kg and ginger 
extract at doses 50, 100 and 200 mg/kg (p.o by 
gavage) in 30 min before training. Extract was 
administered 15 min before scopolamine and 
45 min before the training. 
30 min after the latest treatment, learning 
and memory were evaluated. The operator 
was unaware of the specific treatment groups 
to which an animal belonged. 
The apparatus and procedure were 
basically followed by previous study.
13
 The 
apparatus used for evaluation of the passive 
avoidance task was two-way shuttle box 
(Borj Sanaat Co. Iran), which consisted of 
two adjacent Plexiglas compartments of 
identical dimensions (27×14.5×14 cm). For 
the experimental procedure, on the first day 
(adaptation day) each rat was allowed a 3 
min adaptation period and free access to 
either the light or dark compartment of the 
box to avoidance training and after being 
placed in a shuttle box. Following this 
adaptation period, on the second day 
(training phase), rats were placed in the 
illuminated compartment and 30 second 
later the sliding door was raised. Upon 
entering the dark compartment, the door was 
closed and a 1.5 mA constant-current shock 
was applied for 3 second. After 20 second, 
the rat was removed from the dark 
compartment and placed into home cage. In 
order to test short- and long-term memories, 
24 h after receiving foot shock, the rats were 
placed in illuminated chamber and 30 second 
later the sliding door was raised and the 
latency of entering the dark compartment 
(step-through latency) and the time spent 
there during 5 min were recorded again, 
because the maximum time that was 
considered in this procedure was 300 second. 
The data are expressed as mean values 
with their standard errors. Analysis of data 
was performed using one-way and two-way 
ANOVA. Following a significant P-value, 
post hoc analysis (Tukey’s test) was 
performed for multiple comparisons. 
Statistical analysis was performed using 
SPSS (version 21; SPSS Inc., Chicago, IL, 
USA). A level of P˂0.05 was considered to 
be significant. 
 
RESULTS 
The retention test which was conducted 
24-h after training. The rat was placed in the 
lighted chamber as during PAL training. 30 
second later, the guillotine door was raised, and 
the step-through latency during the retention 
trial (STL) and the time spent in the dark 
compartment (TDC) were recorded up to 300 s. 
If the rat did not enter the dark compartment 
within 300 s, the retention test was terminated 
and a ceiling score of 300 s was assigned. It 
revealed a significant difference in the STL 
among the groups (Figure 1). 
There was a significant difference in 
STL between saline treated control groups 
and ginger treated groups at dose 100 and 
200 mg/kg (P<0.01 and P<0.001, 
respectively). But there was no significant 
difference in STL between extract treated 
group at dose 50 mg/kg and control group. 
Specifically, the STL of scopolamine-treated 
group at dose 1 mg/kg were significantly 
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lower than the saline control group 
(P<0.001). Administration of ginger at doses 
100 and 200 mg/kg to animals that received 
scopolamine (1 mg/kg) resulted in longer 
STL compared to scopolamine-treated 
animals (P<0.001). There was a significant 
difference in STL between extract treated at 
dose 200 mg/kg that received scopolamine 
and saline treated control groups (P<0.05). 
Also, there was a statistically significant 
difference in TDC among the experimental 
groups (Figure 2). 
 
 
Figure 1: Effect of ginger on the step-through latency in the training (STL) of passive 
avoidance learning (PAL) task in the rats 
Columns represent mean ± SEM; 
*
P<0.05, 
**
P<0.01, 
***
P<0.001 as compared with its related Control (Ctrl) 
group. 
###
P<0.001, as compared with its related scopolamine (Sco) received group. 
 
Figure 2: Effect of ginger on the time spent in the dark compartment in the training (TDC) which 
was carried out 24 h after acquisition of passive avoidance learning (PAL) task in the groups 
Columns represent mean ± SEM; 
*
P<0.05, 
**
P<0.01 as compared with control (Ctrl) group. 
###
P<0.001 as 
compared with scopolamine (Sco) treated group. 
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Consistent with a cognitive impairment, 
TDC of the scopolamine-treated rats was 
greater than the saline treated control group 
(P<0.01). Time spent in the dark 
compartment in the groups that treated 
extract at doses 100 and 200 mg/kg was 
significantly less than the respective saline 
treated control group (P<0.01). Also, it was a 
significant difference in TDC between ginger 
extract treated at doses 100 and 200 mg/kg 
that received scopolamine and scopolamine-
treated groups (P<0.001). There was a 
statistically significant difference in TDC 
between extract treated at dose 50 mg/kg that 
received scopolamine than the extract treated 
groups at doses 100 and 200 mg/kg that 
received scopolamine (P<0.001). TDC in the 
group that treated extract at doses 50 mg/kg 
was significantly less than the respective 
extract treated group at doses 50 mg/kg that 
received scopolamine (P<0.05). 
 
DISCUSSION 
Cholinergic neurons in the basal 
forebrain and hippocampus, and 
acetylcholine as a major neurotransmitter 
in these neurons, have important roles in 
learning and memory processes.
14
 Age-
related dementia and memory deficit 
observed in AD, are correlated with the 
loss of cholinergic neurons in the basal 
forebrain and hippocampus.
15
 In addition, 
pharmacological blockage of cholinergic 
neurons in these areas causes impairment 
of memory and learning in experimental 
animals.
16
 Several studies have employed 
scopolamine; a nonselective muscarinic 
receptor antagonist, treated animals as a 
test model of cognitive function,
5
 and this 
model has been widely used to investigate 
the role of the cholinergic system in 
learning and memory and test new 
substances, designed to treat cognitive 
dysfunction.
3,17
 In the present study, 
preventive effect of ginger on learning and 
memory deficits was investigated using a 
scopolamine-induced memory impairment 
rat model. The results of the present study 
show that treatment with 50, 100 and  
200 mg/kg ginger improved PAL and 
memory of control rats and alleviated the 
negative influence of scopolamine on 
learning and memory. The decrease in the 
number of trials to acquisition in the PAL 
task is evidence of an improvement in 
memory acquisition. The increase in STL 
and decrease in TDC during the retention 
test demonstrates facilitative effects on 
memory retention.
18
 
It has been shown that the degree of 
memory impairment is related to the degree 
of cholinergic loss in early Alzheimer's 
disease.
19
 These findings are further 
supported by evidence that ACh modulates 
exploratory behavior in animals,
20
 and a 
host of pharmacological studies showed 
that manipulating cholinergic transmission 
affects learning and memory in humans
21
 
and animals.
22
 Further, it is reported that 
cholinergic transmission is associated with 
the performance of memory and cue 
detection.
23
 Our current experiments 
expand on these reports and demonstrate 
the potential for ginger to protect against 
memory impairment in scopolamine-
induced animals. The results are quite 
promising. Administration of ginger extract 
clearly prevented the learning and memory 
impairments caused by scopolamine 
administration. Indeed, administration of 
50, 100 and 200 mg/kg ginger to 
scopolamine-induced animals reversed the 
increased number of trials to acquisition, 
indicative of a preventive effect of the 
treatment on acquisition deficits. In the 
retention trial, decreased STL and increased 
TDC of diabetic rats were also reversed by 
ginger treatment. 
The determined Acetylcholinesterase 
(AChE) inhibitory activity agreed with some 
earlier reports where plant phytochemicals 
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from Citrus medica inhibited 
Acetylcholinesterase (AChE)
24
 and plants 
extracts of Ginkgo biloba and Salvia 
lavandulaefolia, showed a significant 
improvement in cognitive performance and 
memory.
25
 In the past, different studies have 
shown that ginger possesses anxiolytic 
properties,
26
 improves inhibitory avoidance 
learning,
27
 facilitates spatial learning along 
with reducing oxidative stress,
28
 inhibits  
β-amyloid peptide-induced cytokine and 
chemokine expression in monocytes. Thus, 
it is delaying the onset and progression of 
neurodegenerative disorders.
29
 Moreover, 
extract of this plant and its active 
components, [6]-gingerol, also inhibited the 
cholinesterase activity which in turn 
increased acetylcholine, a neurotransmitter 
that plays an important role in learning and 
memory.
30
 Therefore, taking all data 
together, we suggest that the cognitive 
enhancing effects of ginger might be partly 
associated with the modulation effect of 
extract in this plant on the alteration of both 
the monoamine system and the cholinergic 
system in various brain areas, including the 
prefrontal cortex and hippocampus. 
However, the precise underlying mechanism 
and possible active ingredient responsible 
for the cognitive enhancing effect of ginger 
still require further investigation. 
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CONCLUSION 
In conclusion in the present study we 
demonstrated that ginger hydroethanolic 
extract could attenuate scopolamine-induced 
memory impairment in rats. Ginger extract 
may provide a new potential alternative for 
prevention of the neurodegeneration and 
impaired cognitive functions, and may 
warrant further clinical studies. 
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